scispace - formally typeset
K

Kimon Stamatelopoulos

Researcher at National and Kapodistrian University of Athens

Publications -  251
Citations -  6993

Kimon Stamatelopoulos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Blood pressure & Medicine. The author has an hindex of 39, co-authored 206 publications receiving 5470 citations. Previous affiliations of Kimon Stamatelopoulos include Alexandra Hospital & Newcastle University.

Papers
More filters
Journal ArticleDOI

Effect of coffee on endothelial function in healthy subjects: the role of caffeine.

TL;DR: Coffee exerts an acute unfavourable effect on the endothelial function in healthy adults, lasting for at least 1 h after intake, which might be attributed to caffeine.
Journal ArticleDOI

A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis.

TL;DR: Whether these beneficial arterial changes are direct effects of the IL-6/IL-6 receptor pathway inhibition, maintained over time and translate into better clinical outcome warrants further studies.
Journal ArticleDOI

Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease.

TL;DR: Accumulating evidence supports the utility of non-invasive markers of subclinical atherosclerosis, namely carotid intimal media thickness, flow mediated dilatation of the brachial artery, augmentation index or pulse wave velocity, in the prediction of cardiovascular risk particularly in primary prevention settings.
Journal ArticleDOI

Platelet-derived chemokines in inflammation and atherosclerosis

TL;DR: The role of platelet-derived chemokines in inflammation and atherosclerosis is focused on and the clinical value of plasma levels of chemokine in the prognosis of atherosclerotic heart disease is discussed.
Journal ArticleDOI

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.

TL;DR: In this paper, the authors discuss SARS-CoV-2 life cycle and a number of approaches aiming to suppress viral infection rates or propagation; increase virus antigen presentation in order to activate a robust and durable adaptive immune response from the host, and/or mitigate the ARDS-related "cytokine storm" and collateral tissue damage that triggers the severe life-threatening complications of COVID-19.